Disparities in patient-reported distress in head and neck cancer.

Authors

Melissa Christina White

Melissa Christina White

Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC

Melissa Christina White , Rong Jiang , Trinitia Y Cannon , Tammara L Watts , Cheyenne Corbett , Nosayaba Osazuwa-Peters

Organizations

Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Duke University School of Medicine, Durham, NC, Duke University Medical Center, Durham, NC, Duke Cancer Institute, Durham, NC, Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC

Research Funding

No funding received

Background: Distress is common among cancer patients, and impacts morbidity and mortality. Head and neck cancer (HNC) is considered one of the most emotionally distressing of all cancers, and given the stark racial disparities in HNC outcomes, we sought to examine racial and sociodemographic factors associated with clinically meaningful distress in a cohort of patients with HNC. Methods: We built a retrospective cohort of patients at a semi-urban, academic, National Cancer Institute (NCI)-designated comprehensive cancer center in the Southeastern United States. Cohort included patients with a diagnosis of HNC who received care from the Radiation Oncology department 5 weeks or less of initial diagnosis, from 2017 to 2022. Outcome of interest was clinically meaningful distress, a binary variable defined as a score of ≥4 on the distress thermometer (DT), a validated tool measuring distress, with scores ranging from 0-10. Main independent variables were sociodemographic factors (race/ethnicity, age, sex, marital status, and health insurance status). We further adjusted for clinical variables (stage of presentation, anatomical subsites, smoking and alcohol history), and problem list domain items. Using chi-square tests and multinomial regression analysis, we estimated differences in distress and odds of meaningful distress by sociodemographic factors, adjusting for clinical factors and problem list domains. Results: From a primary sample of 1,167 patients, 507 patients met our inclusion criteria. Nearly half (45.8%) of our sample had clinically meaningful distress, with a median DT score of 3 (IQR, 0-6). Total number of problem list items and physical concerns showed significant racial differences (p< 0.05); however, in our final models, race was not significantly associated with clinically meaningful distress. Compared to those unmarried, married patients were significantly less likely to report distress (aOR = 0.62; 95% CI: 0.40, 0.95). Also, patients with emotional problems had double the odds of reporting clinically meaningful distress (aOR = 2.03; 95% CI: 1.02, 4.08). Other factors associated with significant clinical distress included tobacco history, and reported practical problems. Conclusions: Marital status and reported emotional problems are significantly associated with clinically meaningful distress in patients with HNC. Our study underscores the need for social support in mitigating distress and optimizing mental healthcare in our patient population. Further studies will explore distress trajectories across the HNC continuum and impact on HNC outcomes.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 257)

DOI

10.1200/OP.2024.20.10_suppl.257

Abstract #

257

Poster Bd #

E2

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Quality Care Symposium

Opioid tapering and discontinuation for head and neck cancer (HNC) survivors.

First Author: Talya Salz

First Author: Emily Castellanos